Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Roisín M. Connolly(Johns Hopkins University), Vered Stearns(Johns Hopkins University), Hui Shen(Van Andel Institute), John H. Fetting(Johns Hopkins University), Rachel C. Jankowitz(University of Pennsylvania), Leslie Cope(Bloomberg (United States)), George Somlo(City Of Hope National Medical Center), Penny Powers(Parkland Health & Hospital System), Peter W. Laird(Van Andel Institute), Antonio C. Wolff(Johns Hopkins University), James G. Herman(UPMC Hillman Cancer Center), Daniel J. Weisenberger(University of California, Los Angeles), Adam Brufsky(University of Pittsburgh), Nancy E. Davidson(WinnMed), Richard Piekarz(Yeshiva University), Cynthia A. Zahnow(Johns Hopkins University), Stephen B. Baylin(Johns Hopkins University), Agustin A. García(University of Southern California), Peter A. Jones(Van Andel Institute), Nita Ahuja(Johns Hopkins University), Huili Li(Johns Hopkins University), Zhe Zhang(Johns Hopkins University), Stacie C. Jeter(Johns Hopkins University), Shannon A. Slater(Parkland Health & Hospital System), Michelle A. Rudek(Dana-Farber Cancer Institute)
Cited by 160
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k